Cipla Gets U.S. FDA Nod For Generic Inhaler Amid Coronavirus Pandemic
Cipla House, the headquarters of Cipla Ltd. in Lower Parel area of Mumbai, India. (Photo: BloombergQuint)

Cipla Gets U.S. FDA Nod For Generic Inhaler Amid Coronavirus Pandemic

Cipla Ltd. has received the U.S. drug regulator’s approval to make the first generic of a commonly used inhaler to treat breathing difficulties as demand surges amid the coronavirus pandemic.The U....
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.